跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CD7 CAR-T cells
首页
药物
CD7 CAR-T cells
CD7 CAR-T cells
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
USE OF CD2/5/7 KNOCK-OUT ANTI-CD2/5/7 CHIMERIC ANTIGEN RECEPTOR T CELLS AGAINST T CELL LYMPHOMAS AND LEUKEMIAS
EP 3898692 A4
申请人: UNIV PENNSYLVANIA
优先权: 2018
CN
EP
US
WO
9 件公开
ANTI-CD7 NANOBODY, AND DERIVATIVE THEREOF AND USE THEREOF IN TUMOR THERAPY
EP 4501962 A4
申请人: HEBEI SENLANG BIOTECHNOLOGY CO LTD
优先权: 2022
CN
EP
US
WO
6 件公开
MODIFIED INVARIANT NATURAL KILLER T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
EP 4482501 A4
申请人: TINKESO THERAPEUTICS INC
优先权: 2022
CN
EP
US
WO
4 件公开
ANTIBODY TARGETING HUMAN CD7 OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF
EP 4748858 A1
申请人: NANJING PROBIO BIOTECH CO LTD
优先权: 2023
CN
EP
WO
4 件公开
MODIFIED IMMUNE EFFECTOR CELLS AND USES THEREOF
US 20250161358 A1
申请人: UTC THERAPEUTICS SHANGHAI CO LTD
优先权: 2022
CN
US
2 件公开
T-CELL ANTIGEN TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR) AND USES IN CELL THERAPIES
CN 110944652 A
申请人: UNIV EMORY
优先权: 2017
CN
Two gene vectors for generating CAR-T (chimeric antigen receptor T) cells and application of two gene vectors
CN 120519520 A
申请人: MEDISYX THERAPEUTICS PTY LTD
优先权: 2018
CN
CD7-targeted engineered immune cell, chimeric antigen receptor, CD7 blocking molecule and application
CN 115947852 A
申请人: SHANGHAI YAKE BIOLOGICAL SCIENCE & TECH CO LTD
优先权: 2021
CN
CD7-BASED HUMANIZED CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
US 20250222026 A1
申请人: BEIJING MEIKANG GENO IMMUNE BIOTECHNOLOGY CO LTD
优先权: 2021
US
Chimeric antigen receptor targeting CD7 protein and application thereof
CN 116789844 A
申请人: SHANGHAI FIRST PEOPLES HOSPITAL
优先权: 2022
CN
第 1 / 2 页
上一页
下一页
药物
反馈